Extracorporeal life support in pregnant and postpartum women with COVID-19-related acute respiratory distress syndrome

AM El Banayosy, A El Banayosy, JG Smith, JM Brewer, MR Mihu, LV Swant, RS Schoaps, A Sharif, C Benson, MO Maybauer Int J Artif Organs DOI 10.1177/03913988231168431

Abstract: Extracorporeal membrane oxygenation (ECMO) is an intervention used for patients with acute respiratory distress syndrome (ARDS) from COVID-19 who have failed conventional ventilatory strategies. Very few studies have given insight into the outcomes of pregnant and postpartum patients requiring ECMO support.

Previous
Previous

Oxygenated right ventricular assist device as part of veno-venopulmonary extracorporeal membrane oxygenation to support the right ventricle and pulmonary vasculature

Next
Next

Defining effective communication for critically ill patients with an artificial airway: An international multi-professional consensus